MERCK KGAA O.N./ DE0006599905 /
2024-03-28 10:59:14 PM | Chg. +3.300 | Volume | Bid10:59:14 PM | Ask10:59:14 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
162.800EUR | +2.07% | - Turnover: - |
162.800Bid Size: - | 164.200Ask Size: - | 21.05 bill.EUR | 1.35% | 25.10 |
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA